2019 Dosage Pharmaceutical Companies 
The Checkup by Singlecare
MARCH 8, 2024
The pharmaceutical company that makes Amjevita is called Amgen, Inc. The pharmaceutical company that makes Cyltezo is called Boehringer Ingelheim Pharmaceuticals, Inc. The pharmaceutical company that makes Hyrimoz is called Cordavis Limited. Cyltezo is citrate-free.
The Checkup by Singlecare
AUGUST 29, 2023
Although a generic was approved in 2019, generic apixaban will not be available on the market until at least April 2028. The first generics of apixaban were announced in December 2019. The FDA approved two applications for generic versions of Eliquis by the companies Micro Labs Limited and Mylan Pharmaceuticals, Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 23, 2022
2 The global counterfeit pharmaceuticals trade is estimated to be worth billions annually, 3 bolstered significantly by the increased illicit online pharmacies that emerged during the COVID-19 pandemic. 2019; Available from: [link]. Some, 250,000 child deaths per year can be attributed to counterfeit malaria and pneumonia medicines.
The Checkup by Singlecare
APRIL 19, 2024
Farxiga is an oral prescription drug containing the active ingredient dapagliflozin and made by the pharmaceutical company AstraZeneca. The indication was based on a clinical trial published in 2019 in the New England Journal of Medicine (NEJM). Farxiga is one of the treatment options for heart failure.
Pharmaceutical Technology
SEPTEMBER 22, 2022
The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. GlobalData is the parent company of Pharmaceutical Technology. Following this, in 2019, the FDA approved Vazkepa for the reduction of cardiovascular risk.
The Checkup by Singlecare
OCTOBER 9, 2024
Food and Drug Administration (FDA) in 2019 and is made by the pharmaceutical company Janssen Pharmaceuticals. The cost will depend on the dosage, and can add up to thousands per month. From weeks 5 through 8, the dosage is 56 mg or 84 mg once per week. Spravato was approved by the U.S.
European Pharmaceutical Review
SEPTEMBER 29, 2022
Some drug products are susceptible to active pharmaceutical ingredient (API) shortages for a variety of reasons and bifurcation in the market for finished dosage form product between brand and generic drugs, for example, likewise can affect the degree of competition and product diversification in a market. October 2019.
Expert insights. Personalized for you.
97 
Let's personalize your content